AKEBIA THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
AKEBIA THERAPEUTICS, INC. (AKBA) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $896.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-08
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $896.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.79M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $2.69M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $886.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $896.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.79M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.69M 10-Q · filed 2018-05-09 |
| 2017-09-30 | $886.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.77M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.66M 10-Q · filed 2017-05-09 |
| 2016-09-30 | $714.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.43M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $2.14M 10-Q · filed 2016-05-05 |
| 2015-09-30 | $230.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $460.00K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $690.00K 10-Q · filed 2015-05-11 |
| 2014-09-30 | $94.01K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $188.02K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $282.03K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |